Literature DB >> 34297256

Endoscopic Management of Bariatric Surgery Complications According to a Standardized Algorithm.

Andrea Spota1,2, Fabrizio Cereatti1,3, Stefano Granieri4, Giulio Antonelli3, Jean-Loup Dumont1, Ibrahim Dagher5, Renaud Chiche6, Jean-Marc Catheline7, Guillaume Pourcher8, Lionel Rebibo9, Daniela Calabrese9, Simon Msika9, Hadrien Tranchart5, Panagiotis Lainas5, David Danan1, Thierry Tuszynski1, Filippo Pacini10, Roberto Arienzo10, Nelson Trelles11, Antoine Soprani6, Andrea Lazzati12, Adriana Torcivia13, Laurent Genser13, Serge Derhy14, Maurizio Fazi1, Jean-Luc Bouillot15, Jean-Pierre Marmuse16, Jean-Marc Chevallier10, Gianfranco Donatelli17.   

Abstract

BACKGROUND AND AIMS: Endoscopy is effective in management of bariatric surgery (BS) adverse events (AEs) but a comprehensive evaluation of long-term results is lacking. Our aim is to assess the effectiveness of a standardized algorithm for the treatment of BS-AE. PATIENTS AND METHODS: We retrospectively analyzed 1020 consecutive patients treated in our center from 2012 to 2020, collecting data on demographics, type of BS, complications, and endoscopic treatment. Clinical success (CS) was evaluated considering referral delay, healing time, surgery, and complications type. Logistic regression was performed to identify variables of CS.
RESULTS: In the study period, we treated 339 fistulae (33.2%), 324 leaks (31.8%), 198 post-sleeve gastrectomy twist/stenosis (19.4%), 95 post-RYGB stenosis (9.3 %), 37 collections (3.6%), 15 LAGB migrations (1.5%), 7 weight regains (0.7%), and 2 hemorrhages (0.2%). Main endoscopic treatments were as follows: pigtail-stent positioning under endoscopic view for both leaks (CS 86.1%) and fistulas (CS 77.2%), or under EUS-guidance for collections (CS 88.2%); dilations and/or stent positioning for sleeve twist/stenosis (CS 80.6%) and bypass stenosis (CS 81.5%). After a median (IQR) follow-up of 18.5 months (4.29-38.68), complications rate was 1.9%. We found a 1% increased risk of redo-surgery every 10 days of delay to the first endoscopic treatment. Endoscopically treated patients had a more frequent regular diet compared to re-operated patients.
CONCLUSIONS: Endoscopic treatment of BS-AEs following a standardized algorithm is safe and effective. Early endoscopic treatment is associated with an increased CS rate.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adverse events; Bariatric surgery; Double pigtail; Endoscopic internal drainage; Endoscopy; Fistula; Gastric by-pass; LAMS; Lap band; Leak; SEMS; Sleeve gastrectomy; Stenosis; Stricture; Twist

Year:  2021        PMID: 34297256     DOI: 10.1007/s11695-021-05577-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  2 in total

Review 1.  Postoperative diet advancement: surgical dogma vs evidence-based medicine.

Authors:  Jeremy Warren; Varun Bhalla; Gail Cresci
Journal:  Nutr Clin Pract       Date:  2011-04       Impact factor: 3.080

2.  Lumen-apposing covered self-expanding metal stent for management of benign gastrointestinal strictures.

Authors:  Shounak Majumder; Navtej S Buttar; Christopher Gostout; Michael J Levy; John Martin; Bret Petersen; Mark Topazian; Louis M Wong Kee Song; Barham K Abu Dayyeh
Journal:  Endosc Int Open       Date:  2015-12-15
  2 in total
  2 in total

1.  Stent Management of Leaks After Bariatric Surgery: a Systematic Review and Meta-analysis.

Authors:  Andreu Martínez Hernández; Homero Beltrán Herrera; Vicente Martínez García; Miguel Ibáñez Belenguer; Raquel Queralt Martín; Ana Karina Maiocchi Segredo; Elena Aliaga Hilario; José Manuel Laguna Sastre
Journal:  Obes Surg       Date:  2022-02-07       Impact factor: 4.129

2.  Endoscopic treatment of large gastric leaks after gastrectomy using the combination of double pigtail drains crossing a covered stent.

Authors:  Yzet Clara; Hakim Sami; Pioche Mathieu; Le Mouel Jean-Phillippe; Deschepper Constance; Lafeuille Pierre; Delcenserie Richard; Yzet Thierry; Nguyen-Khac Eric; Fumery Mathurin; Brazier Franck
Journal:  Surg Endosc       Date:  2022-10-03       Impact factor: 3.453

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.